Introduction: Treatment of sarcoidosis recommendations are often based on clinical
experience and expert opinion. However, there are an increasing number of studies which …

The options for treatment of sarcoidosis have expanded. In this article, we outline a stepwise
approach to treatment. Recommendations for treatment are based on available evidence …

Sarcoidosis is a systemic, granulomatous disease that can affect multiple organs and has a
variable clinical course. Corticosteroids (eg prednisone) remain the mainstay of therapy in …

Not all patients who have sarcoidosis require treatment. For those who require treatment, the
outcome of sarcoidosis can be considered conceptually in three broad, and at least partially …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

In general, sarcoidosis treatment should be offered to palliate symptoms and improve quality
of life or to prevent end-organ disease. Symptoms include pulmonary as well as extra …

Most cases of sarcoidosis are mild and self-limited, with a spontaneous cure. However, in
some patients, this disease may also be life-threatening, particularly when severe …

Introduction: Sarcoidosis is a systemic disease of unknown etiology characterized by the
development of non-caseating epitheloid granulomas. The lungs are the most commonly …

The treatment of sarcoidosis remains controversial. Corticosteroids remain the cornerstone
of therapy, but immunosuppressive, cytotoxic, and immunomodulatory agents have emerged …

Sarcoidosis is a multi-system disease of unknown etiology characterized by granuloma
formation in various organs (especially lung and mediastinohilar lymph nodes). In more than …